Plasma acylcarnitines could predict prognosis and evaluate treatment of IgA nephropathy
Abstract Background Effective evaluation or prediction of therapy response could be helpful for treatment of chronic kidney disease (CKD), which may rely on accurate biomarkers. Acylcarnitines are involved with lipid metabolism and mitochondrial function. The relation of acylcarnitines with treatmen...
Main Authors: | Fang-Ying Xia, Li Zhu, Chao Xu, Qing-Qing Wu, Wan-Jia Chen, Rong Zeng, Yue-Yi Deng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | Nutrition & Metabolism |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12986-018-0328-1 |
Similar Items
-
Comparative study on clinicopathological features and prognosis of IgA vasculitis nephritis and IgA nephropathy in children
by: Yan Lv, et al.
Published: (2023-08-01) -
Glomerular Galactose-Deficient IgA1(KM55) Positive May Predict Poorer Prognosis in Coexisting Primary Membranous Nephropathy and IgA Nephropathy Patients
by: Wenrong Cheng, et al.
Published: (2022-12-01) -
Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
by: Yoshihito Nihei, et al.
Published: (2023-04-01) -
The impact of metabolic component count on IgA nephropathy prognosis
by: Hui Ma, et al.
Published: (2024-12-01) -
Relationship between IgM deposition in the mesangial region and the prognosis of IgA nephropathy: a single-centre retrospective study
by: Li Gao, et al.
Published: (2024-11-01)